Case Reports

​

Every UPC, EPO and national court decision our fee earners have written up — now filterable by the same 40+ tags they already use to classify each report, plus the court and industry sector behind it.

Tags
No tags match that search.
Court
No courts match that search.
Sector
No sectors match that search.
0 of 100
Case Reports
Tag
Clear all
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
​
Tag
:
Tag

Court of Appeal gives Babek’s trade mark a gold star for validity

18 December 2025
2025-12-18

The Court of Appeal upheld the validity of Babek International Ltd’s trade mark after Iceland Foods Ltd challenged its registration. The judgment clarified that a trade mark must be a single, clearly and precisely represented sign capable of distinguishing goods or services. The court found that Babek’s mark met these requirements, rejecting arguments about lack of clarity and permissible variations. Iceland’s appeal was dismissed, affirming the trade mark’s validity and providing guidance on interpreting trade mark descriptions and representations.

#
Appeal
No items found.
No items found.
​

Mannheim LD asserts extraterritorial jurisdiction over non-EU defendant

15 December 2025
2025-12-15

Hurom v. NUC UPC-CFI_162/2024 LD Mannheim Decision of 2 October 2025

#
UPC
#
Infringement
#
Jurisdiction
No items found.
No items found.
​

Another day, another interim injunction granted by the UK High Court: Boehringer Ingelheim find success against Dr Reddy

04 December 2025
2025-12-04

Boehringer Ingelheim successfully obtained another interim injunction from the UK High Court against Dr Reddy, reinforcing its patent rights in ongoing pharmaceutical litigation. The article outlines the case details, the court’s reasoning, and what this decision means for patent enforcement in the UK.

#
Basic
No items found.
No items found.
​

When is a managing director an accomplice to patent infringement?

26 November 2025
2025-11-26

#
UPC
#
Infringement
#
Other procedural aspects
No items found.
No items found.
​

Court of Appeal of the UPC considers post-filed experimental data irrelevant to claim construction

25 November 2025
2025-11-25

#
Recent cases
#
UPC
#
Claim interpretation
No items found.
No items found.
​

Auxiliary claim requests inadmissible and indicative of likely invalidity in applications for provisional measures.

25 November 2025
2025-11-25

The UPC’s Munich Local Division denied Onward Medical’s bid for a preliminary injunction against Niche Biomedical, finding serious doubts over the novelty of the granted claim of EP 3 421 081 B1 in light of the Yoo prior art. The court also rejected all eight auxiliary claim requests, holding that amended claims cannot be used to establish likely validity in provisional‑measures proceedings. The decision reinforces that interim relief is only available for patents that appear robust in their granted form.

#
Recent cases
#
UPC
#
Permanent injunction
No items found.
No items found.
​

UPC continues the Mushroom Saga with decision by default

20 November 2025
2025-11-20

#
UPC
#
Recent cases
#
Infringement
No items found.
No items found.
​

No Declaration of Non-Infringement for Alternative Product

12 November 2025
2025-11-12

The Unified Patent Court rejected Black Sheep’s request for a declaration of non-infringement (DNI) for an alternative product design. The court found the request inadmissible because HL Display had not asserted infringement against the alternative design, and Black Sheep had not formally sought acknowledgment of non-infringement before filing the counterclaim.

#
Infringement
#
UPC
#
Recent cases
No items found.
No items found.
​

UPC sets out Guidelines for Penalty Payments

04 November 2025
2025-11-04

Kodak v. Fujifilm (UPC CoA 699/2025, order of 14 October 2025)[1] According to Art. 82(2) UPCA and Rule 354.3 RoP, a party may be sanctioned with a recurring penalty payment, payable to the UPC, if...

#
UPC
#
Recent cases
#
Penalty payment
No items found.
No items found.
​

UPC takes strict approach on costs reimbursement

30 October 2025
2025-10-30

Insulet v. EOFlow UPC_CFI_773/2025 and UPC_CFI 774/2025 (Milan CD), decision of 15 October 2025[1] The dispute began when Insulet sought a provisional injunction against EOFlow to prevent...

#
UPC
#
Recent cases
#
Costs
No items found.
No items found.
​

UPC Considers but does not decide exhaustion of rights in relation to consumables

30 October 2025
2025-10-30

Brita v. Aquashield UPC CFI 248/2024 (Munich LD), decision of 22 August 2025[1] UPC CFI 564/2024 (Munich LD), decision of 16 October 2025[2] Brita sued Aquashield and others for infringement of...

#
UPC
#
Recent cases
#
Infringement
No items found.
No items found.
​

Apple Intervenes in Confidentiality Appeals: UPC Court of Appeal Allows Intervention in Ericsson and Sun Patent Trust Cases

30 September 2025
2025-09-30

Apple (Intervener) in Ericsson v. AsusTek and Apple (Intervener) in Sun Patent Trust v. Vivo UPC_CoA_631/2025[1], UPC_CoA_632/2025[2], UPC_CoA_755/2025[3], and UPC_CoA_757/2025[4] – Orders of 23...

#
UPC
#
Recent cases
#
Confidentiality
#
Intervention
No items found.
No items found.
​

UPC Infringement Actions: Is Speed Meeting Expectations?

23 September 2025
2025-09-23

The Unified Patent Court promised simplified and faster patent litigation across Europe. Two years in, we look at whether it’s delivering on that promise. For patent holders and defendants alike, the duration of infringement actions can significantly impact market strategies, investment decisions, and competitive positioning. In this article, we set out an in-depth analysis of how the court’s procedural rules are shaping the pace of litigation. By examining key milestones—from the filing of an infringement action to the issuance of a final judgment—we assess whether the UPC is delivering on its promise of efficiency.

#
UPC
#
Recent cases
No items found.
No items found.
​

Does an ongoing phase 3 clinical trial and its published protocol suggest that the tested drug will be successful?

18 September 2025
2025-09-18

Summary A recent EPO Boards of Appeal decision, T 0136/24, has examined the issue of "reasonable expectation of success" when the prior art discloses a protocol to an ongoing phase 3 clinical trial.

#
EPO
No items found.
No items found.
​

When “better” isn’t good enough under Art. 84 EPC

18 September 2025
2025-09-18

In the recent Decision T 2387/22, the Board's key message was: if you define an invention by a "relative improvement" of a known technical effect, the improvement must be expressed in "objectively...

#
Stratiphy
#
Life
#
Patenting
#
EPO
No items found.
No items found.
​
No results found.
Please try updating your search criteria.
Stay in the Know

The UPC Newsletter

Get expert insights and the top patent stories delivered straight to your inbox.